Artiva Biotherapeutics Inc. (ARTV) Stock Price, Quote & News

Company Profile

Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. The company's lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody -associa...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 267 4467

Website: www.artivabio.com

Address:

5505 Morehouse Drive, Suite 100, San Diego, United States

Supplement Oct. 3 at 1:27 PM

$ARTV It's so quiet lately. It's kind of eerie. Are we dead or are we about to wake up?

1 · Reply

Supplement Oct. 2 at 3:27 PM

$ARTV

0 · Reply

night_morning Sep. 23 at 3:56 PM

$ARTV garbage stock 6 months with No news + all of its competitors got their stocks pumped above their market cap while this garbage is dumping to the ground

1 · Reply

StockScanners Sep. 23 at 5:42 AM

$ARTV reached 2.71

0 · Reply

StockScanners Sep. 20 at 7:21 PM

$ARTV keep watch if this holds above 2.55

0 · Reply

Teflon_100 Sep. 18 at 6:58 PM

$ARTV I’m in

0 · Reply

BioShark Sep. 18 at 1:35 PM

$ARTV I’m finding this one attractive, got my toes in this one now. Tagging in

0 · Reply

night_morning Sep. 10 at 4:49 PM

$ARTV garbage manipulator is holding the stock down

0 · Reply

NVDAMillionaire Sep. 10 at 6:26 AM

$ARTV Great piece that accurately captures ARTV's current position. So if you want to refresh your understanding of ARTV or learn about ARTV for the first time, this is essential reading. https://beyondspx.com/quote/ARTV/analysis/artiva-biotherapeutics-unlocking-the-allogeneic-nk-cell-frontier-in-autoimmunity-nasdaq-artv

0 · Reply

GluttonBoy Sep. 9 at 6:03 PM

TAIT stock is at zero borrow with shorts trapped and about to have a historic squeeze 3M float with no dilution and is a profitable semiconductor play Watching these too : $STKE $SXTC $ARTV $KWM $VRM

2 · Reply

Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025

Aug 6, 2025, 4:05 PM EDT - 2 months ago

Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights

May 28, 2025, 4:05 PM EDT - 4 months ago

Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference

May 13, 2025, 4:05 PM EDT - 5 months ago

Artiva Biotherapeutics Announces Longer-term Phase 1/2 Data Demonstrating Prolonged Durability for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

May 8, 2025, 8:00 AM EDT - 5 months ago

Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights

Apr 28, 2025, 4:35 PM EDT - 5 months ago

Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

Apr 8, 2025, 4:05 PM EDT - 6 months ago

Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer

Mar 31, 2025, 4:05 PM EDT - 6 months ago

Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Mar 24, 2025, 4:05 PM EDT - 7 months ago

Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights

Feb 20, 2025, 4:05 PM EST - 8 months ago

Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference

Jan 29, 2025, 4:05 PM EST - 8 months ago

Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.

Nov 12, 2024, 4:05 PM EST - 11 months ago

Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 11, 2024, 4:05 PM EST - 11 months ago

Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference

Oct 22, 2024, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

Sep 10, 2024, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference

Aug 29, 2024, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 13, 2024, 2:14 PM EDT - 1 year ago

Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch

Jul 22, 2024, 3:55 PM EDT - 1 year ago

Artiva: Natural Killer Cell Biotech With 1st Half Of 2025 Lupus Treatment Data

Jul 20, 2024, 4:50 AM EDT - 1 year ago

U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO Week

ACTU ARDT BLMZ CON LINE OS QMMM

Jul 18, 2024, 7:08 PM EDT - 1 year ago

Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering

Supplement Oct. 3 at 1:27 PM

$ARTV It's so quiet lately. It's kind of eerie. Are we dead or are we about to wake up?

1 · Reply

Supplement Oct. 2 at 3:27 PM

$ARTV

0 · Reply

night_morning Sep. 23 at 3:56 PM

$ARTV garbage stock 6 months with No news + all of its competitors got their stocks pumped above their market cap while this garbage is dumping to the ground

1 · Reply

StockScanners Sep. 23 at 5:42 AM

$ARTV reached 2.71

0 · Reply

StockScanners Sep. 20 at 7:21 PM

$ARTV keep watch if this holds above 2.55

0 · Reply

Teflon_100 Sep. 18 at 6:58 PM

$ARTV I’m in

0 · Reply

BioShark Sep. 18 at 1:35 PM

$ARTV I’m finding this one attractive, got my toes in this one now. Tagging in

0 · Reply

night_morning Sep. 10 at 4:49 PM

$ARTV garbage manipulator is holding the stock down

0 · Reply

NVDAMillionaire Sep. 10 at 6:26 AM

0 · Reply

GluttonBoy Sep. 9 at 6:03 PM

TAIT stock is at zero borrow with shorts trapped and about to have a historic squeeze 3M float with no dilution and is a profitable semiconductor play Watching these too : $STKE $SXTC $ARTV $KWM $VRM

2 · Reply

stoneblood Sep. 4 at 6:05 PM

$ARTV trading below cash w/ a ~17month runway looks good here around $3

0 · Reply

dbr_island Aug. 27 at 7:42 PM

$ARTV there it goes NHOD PZG is my next BIG load 🚨🚨🚨 WATCH AND LEARN LIKE👇

0 · Reply

ZoneMonitor Aug. 23 at 6:01 AM

$ARTV Artivion Inc is a medical device company focused on aortic repair with steady growth

0 · Reply

kshonstocks Aug. 18 at 6:12 PM

$ARTV cash 5. 83/share https://finance.yahoo.com/quote/ARTV/key-statistics/

0 · Reply

kshonstocks Aug. 18 at 5:32 PM

$ARTV alert key chart area b/o at 150 dma

0 · Reply

d_risk Aug. 7 at 1:13 AM

$ARTV - Artiva Biotherapeutics Inc. Common Stock - 10Q - Updated Risk Factors ARTV’s 10-Q risk update shows broader autoimmune targets for AlloNK, halted B-NHL follow-up, increased financial losses, new regulatory and supply chain risks, expanded IP and commercialization challenges, plus heightened compliance, data security, and disaster vulnerability concerns. #Biotechnology #SupplyChain #RegulatoryCompliance #FinancialRisk #AutoimmuneDisease 🟢 Added 🟠 Removed https://d-risk.ai/ARTV/10-Q/2025-08-06

0 · Reply

ProfitMaker4 Jul. 24 at 4:32 PM

$ARTV Started buying 06/09 and will be buying shares sub $3 until I hit my upper risk limits. $6.93 BV(PS). Recent drop due to delays in PHASE I (AB-101) Trial overblown. Multiple catalyst 1H-2026 along with numerous additional readouts in 2027-2029. PT: $11.50

0 · Reply

Mollita1313 Jul. 24 at 2:26 PM

$ARTV Any news on this??? Crazy that is up 11% already today with low volume

3 · Reply

Supplement Jul. 24 at 1:27 PM

$ARTV With all this upward momentum something has to be brewing behind the scenes. Super exciting to see the SP go up everyday.

0 · Reply

Dumb_money_big_gains Jul. 23 at 7:29 PM

$ARTV market cap is higher, but the sentiment remains.

0 · Reply

Dumb_money_big_gains Jul. 23 at 7:27 PM

$ARTV do we have a little squeeze coming on?

0 · Reply

Supplement Jul. 23 at 7:19 PM

$ARTV We really only have one more hurdle and then we fly. We need to kick down the door at 14 Day RSI at 80% 3.33. #bullishAF

0 · Reply

Market Cap	N/A
Revenue (ttm)	33.49M
Net Income (ttm)	-27.70M
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	N/A
Debt to Equity Ratio	N/A

Volume	342,500
Avg Vol	N/A
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	N/A
Beta	N/A
Analysts	Strong Buy
Price Target	N/A